These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 30135250

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa.
    Knaup J, Gruber C, Krammer B, Ziegler V, Bauer J, Verwanger T.
    Anal Cell Pathol (Amst); 2011; 34(6):339-53. PubMed ID: 22002724
    [Abstract] [Full Text] [Related]

  • 5. Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma.
    Arbiser JL, Fan CY, Su X, Van Emburgh BO, Cerimele F, Miller MS, Harvell J, Marinkovich MP.
    J Invest Dermatol; 2004 Oct; 123(4):788-90. PubMed ID: 15373786
    [Abstract] [Full Text] [Related]

  • 6. Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa.
    Tartaglia G, Cao Q, Padron ZM, South AP.
    Int J Mol Sci; 2021 May 12; 22(10):. PubMed ID: 34065916
    [Abstract] [Full Text] [Related]

  • 7. Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa.
    Rami A, Łaczmański Ł, Jacków-Nowicka J, Jacków J.
    Int J Mol Sci; 2020 Dec 29; 22(1):. PubMed ID: 33383666
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C, Cox G, Mao X, Volz A, Baksh N, Wong T, Fassihi H, Arita K, O'Toole EA, Ocampo-Candiani J, Chen M, Hart IR, Bruckner-Tuderman L, Salas-Alanis JC, McGrath JA, Leigh IM, South AP.
    J Invest Dermatol; 2007 Oct 29; 127(10):2438-44. PubMed ID: 17495952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.
    Martins VL, Caley MP, Moore K, Szentpetery Z, Marsh ST, Murrell DF, Kim MH, Avari M, McGrath JA, Cerio R, Kivisaari A, Kähäri VM, Hodivala-Dilke K, Brennan CH, Chen M, Marshall JF, O'Toole EA.
    J Natl Cancer Inst; 2016 Jan 29; 108(1):. PubMed ID: 26476432
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
    Rodeck U, Uitto J.
    J Invest Dermatol; 2007 Oct 29; 127(10):2295-6. PubMed ID: 17853916
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
    Atanasova VS, Pourreyron C, Farshchian M, Lawler M, Brown CA, Watt SA, Wright S, Warkala M, Guttmann-Gruber C, Hofbauer JP, Fuentes I, Prisco M, Rashidghamat E, Has C, Salas-Alanis JC, Palisson F, Hovnanian A, McGrath JA, Mellerio JE, Bauer JW, South AP.
    Clin Cancer Res; 2019 Jun 01; 25(11):3384-3391. PubMed ID: 30846478
    [Abstract] [Full Text] [Related]

  • 16. Transcriptome-Guided Drug Repurposing for Aggressive SCCs.
    Zauner R, Wimmer M, Dorfer S, Ablinger M, Koller U, Piñón Hofbauer J, Guttmann-Gruber C, Bauer JW, Wally V.
    Int J Mol Sci; 2022 Jan 17; 23(2):. PubMed ID: 35055192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.
    Faden DL, Thomas S, Cantalupo PG, Agrawal N, Myers J, DeRisi J.
    Oral Oncol; 2017 Nov 17; 74():8-14. PubMed ID: 29103756
    [Abstract] [Full Text] [Related]

  • 19. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
    Föll MC, Fahrner M, Gretzmeier C, Thoma K, Biniossek ML, Kiritsi D, Meiss F, Schilling O, Nyström A, Kern JS.
    Matrix Biol; 2018 Mar 17; 66():1-21. PubMed ID: 29158163
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.